The LOW subset was enriched for tumors with a strong intra-tumor infiltrate of CD3+ T cells while the CIMP subsets was enriched for lesions with an excluded CD3+ and CD8+ infiltrate (Supplemental Fig. S9A, B). Here, CD8A is linked to neoplasm.